It is a pharma private limited company based in Pune, Maharashtra, India, established in 2007.
2007 | Pune, Maharashtra, India | ActiveXion Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 2007 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231PN2007PTC130248. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Jodhawat Enterprises Private Limited. It upholds a compliant status. Its leadership includes Mahendra Champalal Jain (Director), Rajeshkumar Champalal Jain (Director), Roshan Champalal Jain (Director). It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.
U24231PN2007PTC130248
130248
04 June 2007
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Xion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendra Champalal Jain | Director | 04 Jun 2007 | Current |
| Rajeshkumar Champalal Jain | Director | 04 Jun 2007 | Current |
| Roshan Champalal Jain | Director | 04 Jun 2007 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xion Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.3% decrease. The company also saw a substantial fall in profitability, with a 93.85% decrease in profit. The company's net worth moved up by a moderate rise of 0.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Xion Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2017 | Others | ₹2.50 M | Open |
| 26 Mar 2014 | The Cosmos Co-Operative Bank Limited | ₹5.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Xion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xion Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Xion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Xion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100080448 was registered on 07 Feb 2017. was documented.
A charge with The Cosmos Co-Operative Bank Limited amounted to Rs. 5.50 M with Charge ID 10495952 was registered on 26 Mar 2014. was recorded as a recent event.
Progress on Mahendra Champalal Jain was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 6 months . was documented.
The activity Rajeshkumar Champalal Jain was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 6 months . was completed.
The CIN of Xion Pharmaceuticals Private Limited is U24231PN2007PTC130248.
Xion Pharmaceuticals Private Limited is headquartered at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.
Xion Pharmaceuticals Private Limited was incorporated on 04 June 2007.
The current directors of Xion Pharmaceuticals Private Limited are
The primary industry of Xion Pharmaceuticals Private Limited is Trade.
Xion Pharmaceuticals Private Limited is unlisted.
The authorized capital of Xion Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Xion Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX